Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if using a new imaging solution,
3'-Deoxy-3'-18f-Fluorothymidine, in a positron emission tomography (PET) scan can help
doctors determine if your brain lesion is from the tumor returning or the effects of previous
treatments.
The results of this imaging scan (called an FLT PET scan) will be compared to the results of
a Magnetic Resonance Imaging scan, which you have already had or are scheduled to have
outside of this study.